Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.


TSX:SVA - Post by User

Bullboard Posts
Post by elgin1on Oct 04, 2019 12:14pm
190 Views
Post# 30196923

Bioteck Viacyte results

Bioteck Viacyte resultsI am surprised you are not chirping about Viacyctes results from their trial.  Mixed results, no endpoint data.... c petitide, how much where ? Insulin production? Sugar reduction?  Where was c peptide?? Inside the device?

Viacycte has tow variables - their device and their stem cells?  Which one works? Dont know... again they use immunosuoreesion too.

At least with Sernova, we have exact endpoint measurements of c peptide. With Medtronics glucose monitoring we have accuarcay of data that is unparallel.  Also with Sernova,  we know the pouch works, introducing stem cell line (that has also proven to work) you eliminate unceratin variables.  Viacyte on the other hand, wont know what or how to modify to improve their results. Viacycte release the data.....    

Hopefully Sernova releases updates on results on existing patient and enrolled patients.  I doubt the big pharma collaboartion will be made public because pharma does not want competitors to know anything.  But it will eventually be made public at some point with a buyout or licensing deal if results look favorable.... just my opinion only.
Bullboard Posts